Contents

Reviews on Recent Clinical Trials, Volume 1 - Number 2

Dendritic Cell Immunotherapy for Melanoma

, 1(2): 87 - 102

Judy C. Peng, Ranjeny Thomas and Keith Dredge


DOI: 10.2174/157488706776876517




Treatment of Relapsed Acute Myeloid Leukaemia

, 1(2): 103 - 111

Jonathan Kell


DOI: 10.2174/157488706776876445




Monoclonal Antibodies Against Epidermal Growth Factor Receptor in Advanced Colorectal Carcinoma: Clinical Efficacy and Markers of Sensitivity&#

, 1(2): 113 - 118

Enric Carcereny and Joan Maurel


DOI: 10.2174/157488706776876463




Clinical Studies with Targeted Toxins in Malignant Glioma

, 1(2): 119 - 131

Nikolai G. Rainov and Ariane Soling


DOI: 10.2174/157488706776876454




Iodine-Refractory Thyroid Carcinoma

, 1(2): 133 - 141

Apar K. Ganti and Ezra E.W. Cohen


DOI: 10.2174/157488706776876526




Is Atorvastatin Superior to Other Statins? Analysis of the Clinical Trials with Atorvastatin Having Cardiovascular Endpoints

, 1(2): 143 - 153

Sheila A. Doggrell


DOI: 10.2174/157488706776876508




Towards a Gene Therapy Clinical Trial for Epidermolysis Bullosa

, 1(2): 155 - 162

Ferrari Stefano, Pellegrini Graziella, Matsui Tatsuya, Mavilio Fulvio and De L. Michele


DOI: 10.2174/157488706776876472




Alefacept - A Drug Review

, 1(2): 163 - 164

Hadar Lev-Tov and Suhail Hadi


DOI: 10.2174/157488706776876481




Efalizumab: A Biological Agent for the Treatment of Psoriasis

, 1(2): 165 - 168

Sarah Hodulik and Suhail Hadi


DOI: 10.2174/157488706776876436




Review: Recent Clinical Trials in Epigenetic Therapy

, 1(2): 169 - 182

Yasuhiro Oki and Jean-Pierre J. Issa


DOI: 10.2174/157488706776876490




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science